Patents by Inventor Jae-eun Park

Jae-eun Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190221294
    Abstract: The inventive concept relates to a multi-dimensional time series data processing device, a health prediction system including the same, and a method of operating the time series data processing device. A time series data processing device according to an embodiment of the inventive concept includes a network interface, a data generator, a predictor, and a processor. The network interface receives the first time series data having the first type. The data generator generates second time series data having a second type based on the first time series data. The predictor generates prediction data based on the first time series data and the second time series data.
    Type: Application
    Filed: December 7, 2018
    Publication date: July 18, 2019
    Applicant: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE
    Inventors: Ho-Youl JUNG, Hwin Dol PARK, Myung-Eun LIM, Jae Hun CHOI, Youngwoong HAN
  • Publication number: 20190208258
    Abstract: An image display device includes: a processor; a memory configured to store channel information corresponding to at least one channel; and at least one program which is stored in the memory and executed by the processor. The program may include instructions for controlling a display so as to move a channel indicator in a first or second direction on a channel scroll bar and to display channel information of a channel corresponding to a point at which the channel indicator is located, in response to a first input of pressing a channel-up or channel-down key for a long time, and for switching a current channel to the channel corresponding to the point at which the channel indicator is located and displaying an image corresponding to the switched channel, in response to a second input of releasing the channel-up or channel-down key.
    Type: Application
    Filed: March 7, 2019
    Publication date: July 4, 2019
    Applicant: SAMSUNG ELECTRONICS CO., LTD.
    Inventors: Dong-won Ok, Jae-oh Park, Han-soo Kim, Ji-eun Byun
  • Publication number: 20190192613
    Abstract: The present disclosure relates to a composition for alleviating, preventing, or treating hyperoxia-induced lung injury, the composition including the WKYMVm peptide as an active ingredient. The composition has an effect of increasing FPR2 activation and ERK phosphorylation, and also has an effect of improving alveolarization and angiogenesis in hyperoxia-induced lung injury models, and thus the composition is anticipated to be usefully used for the alleviation, prevention, or treatment of hyperoxia-induced lung injury, particularly bronchopulmonary dysplasia.
    Type: Application
    Filed: December 3, 2018
    Publication date: June 27, 2019
    Inventors: Yun Sil CHANG, Won Soon PARK, So Yoon AHN, Dong Kyung SUNG, Young Eun KIM, Jae Ho KIM
  • Publication number: 20190190920
    Abstract: A system, method and program product for authenticating a device. An authentication service is provided having: a data management system for periodically collecting and storing signature data from each of a set of registered devices, wherein the signature data includes a plurality of data points, and wherein at least one of the data points includes a device usage characteristic; a system for obtaining a temporal signature state (TSS) vector of a device in response to a transaction request from the device, wherein the TSS vector includes values for a selected subset of the data points forming the signature data; and an authenticator for comparing the TSS vector of the device with stored signature data in order to authenticate the device.
    Type: Application
    Filed: December 15, 2017
    Publication date: June 20, 2019
    Inventors: Jonathan H. Connell, II, Jae-Eun Park, Nalini K. Ratha
  • Publication number: 20190180882
    Abstract: Provided are a device and method for processing multi-dimensional time series medical data. The device for processing multi-dimensional time series medical data according to an embodiment of the present invention includes a network interface, a preprocessing unit, a data analysis unit, and a processor. The network interface may receive time series medical data including first visit data corresponding to the first time and second visit data corresponding to the second time before the first time. The preprocessing unit preprocesses the time series medical data to generate the modeling data. The preprocessing unit is configured to preprocess the first visit data based on a difference between the first time and the second time. The data analysis unit may generate a time series analysis model for predicting future visit data from the modeling data.
    Type: Application
    Filed: July 10, 2018
    Publication date: June 13, 2019
    Applicant: Electronics and Telecommunications Research Institute
    Inventors: Youngwoong HAN, Hwin Dol PARK, Myung-eun LIM, Ho-Youl JUNG, Jae Hun CHOI
  • Publication number: 20190142809
    Abstract: The present invention provides a benzo[d]thiazole derivative or its pharmaceutically acceptable salt, a process for the preparation thereof, and a pharmaceutical composition comprising the same. The benzo[d]thiazole derivative or its pharmaceutically acceptable salt can selectively inhibit the protein-protein interaction between KRS and a laminin receptor (LR), thereby inhibiting migration of cancer cells. Therefore, the benzo[d]thiazole derivative or its pharmaceutically acceptable salt may be usefully applied for preventing or treating the diseases associated with cancer cell metastasis.
    Type: Application
    Filed: July 6, 2017
    Publication date: May 16, 2019
    Applicant: Yuhan Corporation
    Inventors: Se-Woong Oh, Youn Hur, Jin-Hwi Park, Jae-Eun Joo, Ho-Woong Kang, Hyok-Jun Cho, Eui-Chul Lee, Chan-Sun Park, Dong-Hyun Kim, Jong-Gyun Kim, Su-Youn Nam
  • Patent number: 10282677
    Abstract: A method and system are provided. The method includes deriving a set of user attributes from an aggregate analysis of images and videos of a user. The deriving step includes recognizing, by a set of visual classifiers, semantic concepts in the images and videos of the user to generate visual classifier scores. The deriving step further includes deriving, by a statistical aggregator, the set of user attributes. The set of user attributes are derived by mapping the visual classifier scores to a taxonomy of semantic categories to be recognized in visual content. The deriving step also includes displaying, by an interactive user interface having a display, attribute profiles for the attributes and comparisons of the attribute profiles.
    Type: Grant
    Filed: November 5, 2015
    Date of Patent: May 7, 2019
    Assignee: International Business Machines Corporation
    Inventors: Michele Merler, Jae-Eun Park, John R. Smith, Rosario Uceda-Sosa
  • Publication number: 20170324736
    Abstract: Embodiments include method, systems and computer program products for safeguarding biometric data. Aspects include receiving a first biometric data unit and generating a template based upon the first biometric data unit. Aspects also include sending the template to a plurality of external template storage devices, each template storage device having a unique device identifier. Aspects also include generating a biometric query including a second biometric data unit. Aspects also include sending the biometric query to at least some of the plurality of external template storage devices. Aspects also include receiving a match score from at least one of the plurality of template storage devices external to the processor, wherein the match score reflects the degree of similarity between the first biometric data unit and the second biometric data unit.
    Type: Application
    Filed: May 5, 2016
    Publication date: November 9, 2017
    Inventors: Jonathan H. Connell, II, Jae-Eun Park, Nalini K. Ratha
  • Publication number: 20170228812
    Abstract: A method and system optimizing source selection of an online order with the lowest fulfillment cost by considering multiple types of parameters, including shipping costs, backlog costs and markdown savings of the order. The method includes obtaining an order from the order retrieval subsystem of the OMS, selecting the candidate sources, and retrieving data from retailers or shipping companies of each selected candidate sources. The system then calculates the costs and savings parameters of the candidate sources from the retrieved data. The system identifies all possible candidate sourcing selections of the order and calculates the total fulfillment cost of each sourcing selection of the order by adding the shipping costs with the backlog costs, and subtracting the markdown savings of all candidate sources in each sourcing selection. The system identifies the optimized sourcing selection of the order with the lowest fulfillment cost and renders the selection to the OMS.
    Type: Application
    Filed: February 8, 2016
    Publication date: August 10, 2017
    Inventors: JoAnn P. Brereton, Ajay A. Deshpande, Hongliang Fei, Arun Hampapur, Miao He, Kimberly D. Hendrix, Steve Igrejas, Alan J. King, Yingjie Li, Xuan Liu, Christopher S. Milite, Jae-Eun Park, Vadiraja S. Ramamurthy, Joline Ann V. Uichanco, Songhua Xing, Xiao Bo Zheng
  • Publication number: 20170142101
    Abstract: An embodiment of the invention provides a method for secure biometrics matching with split phase client-server matching protocol, wherein a first biometric input is received in an electronic device. The first biometric input is stored in the electronic device as a biometric profile; and, the biometric profile is sent to a server. An additional biometric input is received from a user in the electronic device; and, the additional biometric input is compared to the biometric profile stored in the electronic device to generate a local matching score. The additional biometric input is sent to the server. The local matching score and a remote matching score generated by the at least one server are compared; and, it is determined whether to authenticate the user based on the comparison of the local matching score and the remote matching score.
    Type: Application
    Filed: November 16, 2015
    Publication date: May 18, 2017
    Applicant: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Jonathan H. Connell, II, Jae-Eun Park, Nalini K. Ratha
  • Publication number: 20170132250
    Abstract: A method and system are provided. The method includes deriving a set of user attributes from an aggregate analysis of images and videos of a user. The deriving step includes recognizing, by a set of visual classifiers, semantic concepts in the images and videos of the user to generate visual classifier scores. The deriving step further includes deriving, by a statistical aggregator, the set of user attributes. The set of user attributes are derived by mapping the visual classifier scores to a taxonomy of semantic categories to be recognized in visual content. The deriving step also includes displaying, by an interactive user interface having a display, attribute profiles for the attributes and comparisons of the attribute profiles.
    Type: Application
    Filed: November 5, 2015
    Publication date: May 11, 2017
    Inventors: Michele Merler, Jae-Eun Park, John R. Smith, Rosario Uceda-Sosa
  • Publication number: 20170121380
    Abstract: The present invention relates to compositions and methods for treating fatty liver, steatohepatitis, or liver cirrhosis as well as insulin resistance and aging by administration of a DLK1-Fc fusion protein constructed by conjugation of an extracellular domain of DLK1 or a fragment thereof with a human antibody Fc region. Also provided are health functional foods containing a DLK1-Fc fusion protein constructed by conjugation of an extracellular domain of DLK1 (delta-like 1 homolog) or a fragment thereof with a human antibody Fc region as an active ingredient.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 4, 2017
    Inventors: Young Woo Park, Bum-chan Park, Bong-soo Cha, Yong Ho Lee, Jung Chae Lim, Young-gyu Cho, Joong Kyu Kim, Jae Eun Park, Seok Ho Yoo
  • Patent number: 9639652
    Abstract: A system, method and computer program product for implementing a quiescent current leakage specific model into semiconductor device design and circuit design flows. The leakage model covers all device geometries with wide temperature and voltage ranges and, without the need for stacking factor calculations nor spread sheet based IDDQ calculations. The leakage model for IDDQ calculation incorporates further parasitic and proximity effects. The leakage model implements leakage calculations at different levels of testing, e.g., from a single device to a full chip design, and are integrated within one single model. The leakage model implements leakage calculations at different levels of testing with the leverage of a single switch setting. The implementation is via a hardware definition language code or object oriented code that can be compiled and operated using a netlist of interest, e.g., for conducting a performance analysis.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: May 2, 2017
    Assignee: GLOBALFOUNDRIES INC.
    Inventors: Paul Chang, Jie Deng, Terrence B. Hook, Sim Y. Loo, Anda C. Mocuta, Jae-Eun Park, Kern Rim, Xiaojun Yu
  • Patent number: 9388223
    Abstract: The present invention relates to a myostatin inhibitor comprising extracellular water-soluble domains of delta-like 1 homolog (DLK1) as active ingredients. More particularly, the present invention relates to a composition for inhibiting myostatin activity, comprising, as active ingredients, extracellular water-soluble domains of DLK1 or a deletion mutant of extracellular water-soluble domains of DLK1. The myostatin inhibitor of the present invention is bonded to the myostatin or activin receptor type IIB so as to inhibit the action mechanism of the myostatin, to thereby promote myogenesis and prevent differentiation into fat cells. Therefore, the myostatin inhibitor of the present invention may be used in preventing and treating diseases such as muscular dysplasia that requires differentiation to muscular cells, or metabolic diseases.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: July 12, 2016
    Assignee: Antibody and Receptor Therapeutics Co., Ltd.
    Inventors: Dong Hee Lee, Bum Chan Park, Jae Eun Park, Myeong Hee Jang, Seok Ho Yoo, Hye Nan Kim
  • Patent number: 9372415
    Abstract: A solvent removing apparatus is disclosed. One aspect includes a chamber, a first pump, a silencer, a valve, and a discharge unit. The chamber dries a coating layer formed on a substrate. The first pump intakes a solvent evaporated from the coating layer of the chamber and discharges the inhaled solvent. The silencer reduces discharge noise of the first pump and accommodates a liquefied solvent of the evaporated solvent provided from the first pump. The valve discharges the liquefied solvent accommodated in the silencer. The discharge unit discharges the evaporated solvent provided by the silencer.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: June 21, 2016
    Assignee: Samsung Display Co., Ltd.
    Inventor: Jae Eun Park
  • Patent number: 9364556
    Abstract: The present invention relates to a drug conjugate comprising a cytotoxic drug conjugated to a c-Met specific human antibody. More specifically, the present invention relates to: a drug conjugate comprising a cytotoxic drug conjugated to a c-Met specific human antibody; a pharmaceutical composition for cancer treatment comprising the drug conjugate; and a cancer treatment method comprising a step in which the drug conjugate or pharmaceutical composition is administered to an individual.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: June 14, 2016
    Assignees: Korea Research Institute of Bioscience and Biotechnology, A&RT Co., Ltd.
    Inventors: Young Woo Park, Ki Won Jo, Sun Jeong Jo, Soon Sil Hyun, Jae Eun Park, Seok Ho Yoo, Myeoung Hee Jang, Hye Nan Kim, Chan Woong Park
  • Publication number: 20160110681
    Abstract: A simulator is configured to simulate the fulfillment of orders by nodes. Each node has an inventory of products and is capable of shipping the products to destinations in response to receipt of a corresponding order. The simulator divides the nodes into groups and assigns a different priority to each group based on input provided by a user to the simulator to generate an ordered sequence of priorities. The simulator maintains safety stock data corresponding to each node that indicates minimum quantities of the products required to be present at the corresponding node. The simulator selects a current priority of the sequence and next simulates a first group among the groups having the current priority fulfilling the orders for a given product among the products while a quantity of the given product at each of the nodes in the first group is below the minimum quantity in the corresponding safety stock data.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 21, 2016
    Inventors: JoAnn Piersa Brereton, Ajay Ashok Deshpande, Arun Hampapur, Miao He, Alan Jonathan King, Xuan Liu, Christopher Scott Milite, Jae-Eun Park, Joline Ann Villaranda Uichanco, Songhua Xing, Steven lgrejas, Hongliang Fei, Vadiraja Ramamurthy, Yingjie Li, Kimberly D. Hendrix, Xiao Bo Zheng
  • Publication number: 20160110735
    Abstract: A simulator is configured to simulate the fulfillment of orders by nodes. Each node has an inventory of products and is capable of shipping the products to destinations in response to receipt of a corresponding order. The simulator divides the nodes into groups and assigns a different priority to each group based on input provided by a user to the simulator to generate an ordered sequence of priorities. The simulator maintains safety stock data corresponding to each node that indicates minimum quantities of the products required to be present at the corresponding node. The simulator selects a current priority of the sequence and next simulates a first group among the groups having the current priority fulfilling the orders for a given product among the products while a quantity of the given product at each of the nodes in the first group is below the minimum quantity in the corresponding safety stock data.
    Type: Application
    Filed: December 1, 2015
    Publication date: April 21, 2016
    Inventors: JoAnn Piersa Brereton, Ajay Ashok Deshpande, Arun Hampapur, Miao He, Alan Jonathan King, Xuan Liu, Christopher Scott Milite, Jae-Eun Park, Joline Ann Villaranda Uichanco, Songhua Xing, Steve Igrejas, Hongliang Fei, Vadiraja Ramamurthy, Yingjie Li, Kimberly D. Hendrix, Xiao Bo Zheng
  • Publication number: 20150110815
    Abstract: The present invention relates to a drug conjugate comprising a cytotoxic drug conjugated to a c-Met specific human antibody. More specifically, the present invention relates to: a drug conjugate comprising a cytotoxic drug conjugated to a c-Met specific human antibody; a pharmaceutical composition for cancer treatment comprising the drug conjugate; and a cancer treatment method comprising a step in which the drug conjugate or pharmaceutical composition is administered to an individual.
    Type: Application
    Filed: November 28, 2012
    Publication date: April 23, 2015
    Applicant: Korea Research Institute of Bioscience and Biotechnology
    Inventors: Young Woo Park, Ki Won Jo, Sun Jeong Jo, Soon Sil Hyun, Jae Eun Park, Seok Ho Yoo, Myeoung Hee Jang, Hye Nan Kim, Chan Woong Park
  • Publication number: 20150030595
    Abstract: The present invention relates to a myostatin inhibitor comprising extracellular water-soluble domains of delta-like 1 homolog (DLK1) as active ingredients. More particularly, the present invention relates to a composition for inhibiting myostatin activity, comprising, as active ingredients, extracellular water-soluble domains of DLK1 or a deletion mutant of extracellular water-soluble domains of DLK1. The myostatin inhibitor of the present invention is bonded to the myostatin or activin receptor type IIB so as to inhibit the action mechanism of the myostatin, to thereby promote myogenesis and prevent differentiation into fat cells. Therefore, the myostatin inhibitor of the present invention may be used in preventing and treating diseases such as muscular dysplasia that requires differentiation to muscular cells, or metabolic diseases.
    Type: Application
    Filed: January 3, 2013
    Publication date: January 29, 2015
    Inventors: Dong Hee Lee, Bum Chan Park, Jae Eun Park, Myeong Hee Jang, Seok Ho Yoo, Hye Nan Kim